HomeNXG • CVE
add
NexgenRx Inc
Previous close
$0.29
Year range
$0.18 - $0.35
Market cap
20.62M CAD
Avg Volume
4.54K
P/E ratio
-
Dividend yield
3.45%
Primary exchange
CVE
Market news
Financials
Income Statement
Revenue
Net income
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Revenue | 4.08M | 19.31% |
Operating expense | 3.10M | 16.23% |
Net income | 31.92K | 471.77% |
Net profit margin | 0.78 | 412.00% |
Earnings per share | — | — |
EBITDA | 406.79K | 17.94% |
Effective tax rate | -252.09% | — |
Balance Sheet
Total assets
Total liabilities
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.81M | 42.53% |
Total assets | 30.63M | 6.19% |
Total liabilities | 22.71M | 12.17% |
Total equity | 7.92M | — |
Shares outstanding | 70.92M | — |
Price to book | 3.22 | — |
Return on assets | 0.71% | — |
Return on capital | 2.47% | — |
Cash Flow
Net change in cash
| (CAD) | Jun 2024info | Y/Y change |
|---|---|---|
Net income | 31.92K | 471.77% |
Cash from operations | 986.17K | 59.77% |
Cash from investing | -158.92K | 10.19% |
Cash from financing | -378.72K | 12.94% |
Net change in cash | 448.52K | 8,378.70% |
Free cash flow | 879.92K | 88.48% |
About
Founded
2003
Headquarters
Website
Employees
20
